# Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor

> **NCT00041769** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 360 (—)

## Conditions studied

- HIV Infections

## Interventions

- **PROCEDURE:** Therapeutic Drug Monitoring (TDM)

## Key facts

- **NCT ID:** NCT00041769
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2007-04
- **Final completion:** 2007-08
- **Target enrollment:** 360 (—)
- **Last updated:** 2010-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00041769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00041769, "Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00041769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*